Every day brings new scientific insights into COVID-19, read about two new studies from Sutter Health experts.
Paying it Forward: Sutter Teams with Vitalant to Offer COVID-19 Survivor-Donated Blood Plasma to Patients
New research suggests blood plasma collected from people who have recovered from COVID-19 may help treat patients with severe cases of the disease. Learn how Sutter’s new partnership with Vitalant will deliver this ground-breaking care to patients.
Imagine a future where doctors could predict which therapies will best treat patients with cancer, personalized to a person’s specific type of the disease. That future may become a reality at Sutter, as researchers explore the potential use of artificial intelligence technology and machine learning in clinical practice.
When a global health challenge began endangering communities across Northern California, researchers at Sutter started brainstorming potential solutions to deliver much-needed treatment to people infected with the novel coronavirus. Learn how clinical trials and other research at Sutter are helping bring top-quality care to our patients and communities.
When does a drop of blood become a crystal ball? New screening could change the future of cancer care.
Racing heartbeat? Butterflies in your chest? If it’s not new love, it could be a common heart condition that carries serious consequences.
About 5 million Americans each year are diagnosed with heart valve disease.1 Learn how tiny implantable devices are doing big jobs to restore normal blood flow to the heart’s parts.
According to the U.S. Centers for Disease Control and Prevention (CDC), nearly 13,000 women in the U.S. are diagnosed with cervical cancer each year, but the disease can be prevented with vaccination and appropriate screening. Read how researchers in our network are discovering new ways to prevent and treat cervical cancer.
Cost estimators can be a valuable tool. But are they accurate? New research points to one that provides very accurate estimates for historically complex costs: healthcare.
How blood, urine and gene mutations may unlock secrets to lung cancer treatment options.